MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
cTACE: The Rebirth of Lipiodol?
Lipiodol-based cTACE remains the most well-studied transarterial therapy for hepatocellular carcinoma.
By Ali Kord Valeshabad, MD, MPH; Jeffrey Kuwahara, MD; and Charles E. Ray Jr, MD, PhD, MS
Embolization: A Closer Look
By Christoph A. Binkert, MD, FCIRSE, FSIR, and Charles E. Ray Jr, MD, PhD, MS
